Get caught up! Check out @abc13houston's recent news report on Pulmotect, Inc. here: https://t.co/QGPKa1Aep7… https://t.co/nR3zynLQHt
"Scott and his team are hopeful the drug could be used to help frontline workers protect their lungs against the… https://t.co/l8jWcOeAMT
#FDA approval in hand, we start two Phase-2 clinical trials against #COVID19 this week. Details here:… https://t.co/wnaOQK7iCt
We would like to express our gratitude to all of our doctors, healthcare workers, scientists, and all other essenti… https://t.co/8p1c7TET6I
@pumotect's PUL-042 has successfully prevented & treated a broad range of respiratory infections in animal models,… https://t.co/2NzKbmYtLM
@pulmotect is making plans for a phase II clinical trial to test the ability of their immunemodulator PUL-042 in pr… https://t.co/uc8NGexzIV
Check out @pulmotect's president, Brenton Scott, as he talks about PUL-042 and the pivot from treating pneumonia in… https://t.co/0WbKNaCI0J
Update March 23 2020 - Pulmotect's Chairman, Leo Linbeck III, provides an update on plans for a Phase II clinical t… https://t.co/6Fd5bsuy8x
Pulmotect, Inc. – Bio-pharmaceutical company developing products for severe respiratory diseases https://t.co/OlVm2ArYcW
Mimicking the human lung will provide researchers a unique way to investigate new areas of research for #COPD… https://t.co/gVm4pzrrVY
Similar Businesses
